Copyright Reports & Markets. All rights reserved.

Global Injectable Pain Medication Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Injectable Pain Medication Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Injectable Pain Medication Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • 1.4.3 Central Analgesics
  • 1.5 Market by Application
    • 1.5.1 Global Injectable Pain Medication Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Clinics
    • 1.5.4 Recovery Center
  • 1.6 Coronavirus Disease 2019 (Covid-19): Injectable Pain Medication Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Injectable Pain Medication Industry
      • 1.6.1.1 Injectable Pain Medication Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Injectable Pain Medication Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Injectable Pain Medication Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Injectable Pain Medication Market Perspective (2015-2026)
  • 2.2 Injectable Pain Medication Growth Trends by Regions
    • 2.2.1 Injectable Pain Medication Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Injectable Pain Medication Historic Market Share by Regions (2015-2020)
    • 2.2.3 Injectable Pain Medication Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Injectable Pain Medication Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Injectable Pain Medication Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Injectable Pain Medication Players by Market Size
    • 3.1.1 Global Top Injectable Pain Medication Players by Revenue (2015-2020)
    • 3.1.2 Global Injectable Pain Medication Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Injectable Pain Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Injectable Pain Medication Market Concentration Ratio
    • 3.2.1 Global Injectable Pain Medication Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Injectable Pain Medication Revenue in 2019
  • 3.3 Injectable Pain Medication Key Players Head office and Area Served
  • 3.4 Key Players Injectable Pain Medication Product Solution and Service
  • 3.5 Date of Enter into Injectable Pain Medication Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Injectable Pain Medication Historic Market Size by Type (2015-2020)
  • 4.2 Global Injectable Pain Medication Forecasted Market Size by Type (2021-2026)

5 Injectable Pain Medication Breakdown Data by Application (2015-2026)

  • 5.1 Global Injectable Pain Medication Market Size by Application (2015-2020)
  • 5.2 Global Injectable Pain Medication Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Injectable Pain Medication Market Size (2015-2020)
  • 6.2 Injectable Pain Medication Key Players in North America (2019-2020)
  • 6.3 North America Injectable Pain Medication Market Size by Type (2015-2020)
  • 6.4 North America Injectable Pain Medication Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Injectable Pain Medication Market Size (2015-2020)
  • 7.2 Injectable Pain Medication Key Players in Europe (2019-2020)
  • 7.3 Europe Injectable Pain Medication Market Size by Type (2015-2020)
  • 7.4 Europe Injectable Pain Medication Market Size by Application (2015-2020)

8 China

  • 8.1 China Injectable Pain Medication Market Size (2015-2020)
  • 8.2 Injectable Pain Medication Key Players in China (2019-2020)
  • 8.3 China Injectable Pain Medication Market Size by Type (2015-2020)
  • 8.4 China Injectable Pain Medication Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Injectable Pain Medication Market Size (2015-2020)
  • 9.2 Injectable Pain Medication Key Players in Japan (2019-2020)
  • 9.3 Japan Injectable Pain Medication Market Size by Type (2015-2020)
  • 9.4 Japan Injectable Pain Medication Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Injectable Pain Medication Market Size (2015-2020)
  • 10.2 Injectable Pain Medication Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Injectable Pain Medication Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Injectable Pain Medication Market Size by Application (2015-2020)

11 India

  • 11.1 India Injectable Pain Medication Market Size (2015-2020)
  • 11.2 Injectable Pain Medication Key Players in India (2019-2020)
  • 11.3 India Injectable Pain Medication Market Size by Type (2015-2020)
  • 11.4 India Injectable Pain Medication Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Injectable Pain Medication Market Size (2015-2020)
  • 12.2 Injectable Pain Medication Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Injectable Pain Medication Market Size by Type (2015-2020)
  • 12.4 Central & South America Injectable Pain Medication Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 GlaxoSmithKline
    • 13.1.1 GlaxoSmithKline Company Details
    • 13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
    • 13.1.3 GlaxoSmithKline Injectable Pain Medication Introduction
    • 13.1.4 GlaxoSmithKline Revenue in Injectable Pain Medication Business (2015-2020))
    • 13.1.5 GlaxoSmithKline Recent Development
  • 13.2 Merck
    • 13.2.1 Merck Company Details
    • 13.2.2 Merck Business Overview and Its Total Revenue
    • 13.2.3 Merck Injectable Pain Medication Introduction
    • 13.2.4 Merck Revenue in Injectable Pain Medication Business (2015-2020)
    • 13.2.5 Merck Recent Development
  • 13.3 Pfizer
    • 13.3.1 Pfizer Company Details
    • 13.3.2 Pfizer Business Overview and Its Total Revenue
    • 13.3.3 Pfizer Injectable Pain Medication Introduction
    • 13.3.4 Pfizer Revenue in Injectable Pain Medication Business (2015-2020)
    • 13.3.5 Pfizer Recent Development
  • 13.4 Novartis
    • 13.4.1 Novartis Company Details
    • 13.4.2 Novartis Business Overview and Its Total Revenue
    • 13.4.3 Novartis Injectable Pain Medication Introduction
    • 13.4.4 Novartis Revenue in Injectable Pain Medication Business (2015-2020)
    • 13.4.5 Novartis Recent Development
  • 13.5 Sanofi
    • 13.5.1 Sanofi Company Details
    • 13.5.2 Sanofi Business Overview and Its Total Revenue
    • 13.5.3 Sanofi Injectable Pain Medication Introduction
    • 13.5.4 Sanofi Revenue in Injectable Pain Medication Business (2015-2020)
    • 13.5.5 Sanofi Recent Development
  • 13.6 Bayer
    • 13.6.1 Bayer Company Details
    • 13.6.2 Bayer Business Overview and Its Total Revenue
    • 13.6.3 Bayer Injectable Pain Medication Introduction
    • 13.6.4 Bayer Revenue in Injectable Pain Medication Business (2015-2020)
    • 13.6.5 Bayer Recent Development
  • 13.7 Johson & Johson
    • 13.7.1 Johson & Johson Company Details
    • 13.7.2 Johson & Johson Business Overview and Its Total Revenue
    • 13.7.3 Johson & Johson Injectable Pain Medication Introduction
    • 13.7.4 Johson & Johson Revenue in Injectable Pain Medication Business (2015-2020)
    • 13.7.5 Johson & Johson Recent Development
  • 13.8 Boehringer Ingelheim
    • 13.8.1 Boehringer Ingelheim Company Details
    • 13.8.2 Boehringer Ingelheim Business Overview and Its Total Revenue
    • 13.8.3 Boehringer Ingelheim Injectable Pain Medication Introduction
    • 13.8.4 Boehringer Ingelheim Revenue in Injectable Pain Medication Business (2015-2020)
    • 13.8.5 Boehringer Ingelheim Recent Development
  • 13.9 Sun Pharmaceutical
    • 13.9.1 Sun Pharmaceutical Company Details
    • 13.9.2 Sun Pharmaceutical Business Overview and Its Total Revenue
    • 13.9.3 Sun Pharmaceutical Injectable Pain Medication Introduction
    • 13.9.4 Sun Pharmaceutical Revenue in Injectable Pain Medication Business (2015-2020)
    • 13.9.5 Sun Pharmaceutical Recent Development

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Analgesics refer to drugs that can partially or completely relieve pain. There are two types of non-steroidal anti-inflammatory drugs and central analgesics. The latter is currently mainly used in the treatment of cancer pain, and can also be used for short-term postoperative pain relief.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Injectable Pain Medication market in 2020.
    COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
    The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyses the impact of Coronavirus COVID-19 on the Injectable Pain Medication industry.
    Based on our recent survey, we have several different scenarios about the Injectable Pain Medication YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Injectable Pain Medication will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Injectable Pain Medication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Injectable Pain Medication market in terms of revenue.
    Players, stakeholders, and other participants in the global Injectable Pain Medication market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
    Regional and Country-level Analysis
    The report offers an exhaustive geographical analysis of the global Injectable Pain Medication market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
    Competition Analysis
    In the competitive analysis section of the report, leading as well as prominent players of the global Injectable Pain Medication market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Injectable Pain Medication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Injectable Pain Medication market.
    The following players are covered in this report:
    GlaxoSmithKline
    Merck
    Pfizer
    Novartis
    Sanofi
    Bayer
    Johson & Johson
    Boehringer Ingelheim
    Sun Pharmaceutical
    Injectable Pain Medication Breakdown Data by Type
    Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    Central Analgesics
    Injectable Pain Medication Breakdown Data by Application
    Hospital
    Clinics
    Recovery Center
    Buy now